» Articles » PMID: 22902993

Paclitaxel Inhibits Ovarian Tumor Growth by Inducing Epithelial Cancer Cells to Benign Fibroblast-like Cells

Overview
Journal Cancer Lett
Specialty Oncology
Date 2012 Aug 21
PMID 22902993
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Paclitaxel is commonly used to treat multiple human malignancies, but its mechanism of action is still poorly defined. Human ovarian cancer SKOV3 cells (parental SKOV3) were treated with paclitaxel (1μM) for 2days, and the morphologic changes in the cells were monitored for more than 4months. Parental SKOV3 underwent a markedly morphologic transition from the epithelial to fibroblast-like phenotype following treatment with paclitaxel; the resulting cells were designated as SKOV3-P. The SKOV3-P cells' proliferative ability was assessed via a 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay. The molecular characteristics of these cells were assessed via immunocytochemical staining and Western blot analysis. Their invasiveness and tumor formation ability was evaluated via wound-scratch and colony formation assays. The tumorigenicity of SKOV3-P cells was assessed in vivo after subcutaneous injection of tumor cells between injections of parental and paclitaxel-treated cells in nude mice. SKOV3-P cells have decreased the proliferation and invasion ability, decreased colony-forming ability when cultured in Matrigel and lost their tumor formation as compared with parental SKOV3 cells when injected in nude mice. SKOV3-P cells have decreased expression of E-cadherin, cytokeratin, Snail, PI3K, and P-Akt-Ser473, and increased expression of fibronectin, vimentin, Slug, P27, and PTEN. These results demonstrated that paclitaxel can inhibit tumor growth by inducing ovarian cancer epithelial cells toward a benign fibroblast-like phenotype through dysregulation of previously known pathways involved in the regulation of epithelial to mesenchymal transition (EMT), which may represent a novel mechanism for paclitaxel-induced tumor suppression.

Citing Articles

Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou-Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells.

Ismail J, Shebaby W, Azar Atallah S, Taleb R, Kawrani S, Faour W Biomedicines. 2025; 13(2).

PMID: 40002932 PMC: 11852490. DOI: 10.3390/biomedicines13020520.


Recent Advances of Small Extracellular Vesicles for the Regulation and Function of Cancer-Associated Fibroblasts.

Liang C, Wang M, Huang Y, Yam J, Zhang X, Zhang X Int J Mol Sci. 2024; 25(23).

PMID: 39684264 PMC: 11641781. DOI: 10.3390/ijms252312548.


Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues.

Lim W, Hwang I, Zhang J, Chen Z, Han J, Jeon J Elife. 2024; 12.

PMID: 38536720 PMC: 10972559. DOI: 10.7554/eLife.88830.


Effect of Polyplex Size on Penetration into Tumor Spheroids.

Casadidio C, Hartman J, Mesquita B, Haegebaert R, Remaut K, Neumann M Mol Pharm. 2023; 20(11):5515-5531.

PMID: 37811785 PMC: 10630948. DOI: 10.1021/acs.molpharmaceut.3c00397.


Regenerative potential of multinucleated cells: bone marrow adiponectin-positive multinucleated cells take the lead.

Moein S, Ahmadbeigi N, Adibi R, Kamali S, Moradzadeh K, Nematollahi P Stem Cell Res Ther. 2023; 14(1):173.

PMID: 37403181 PMC: 10320956. DOI: 10.1186/s13287-023-03400-w.


References
1.
Ahn H, Kim Y, Kim J, Han S, Shin J, Yang H . Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells. J Cell Biochem. 2004; 91(5):1043-52. DOI: 10.1002/jcb.20006. View

2.
Yang G, Rosen D, Liu G, Yang F, Guo X, Xiao X . CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res. 2010; 16(15):3875-86. PMC: 2930833. DOI: 10.1158/1078-0432.CCR-10-0483. View

3.
Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E . The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001; 7(6):1267-78. DOI: 10.1016/s1097-2765(01)00260-x. View

4.
Gradl D, Kuhl M, Wedlich D . The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol. 1999; 19(8):5576-87. PMC: 84410. DOI: 10.1128/MCB.19.8.5576. View

5.
Jing Y, Han Z, Zhang S, Liu Y, Wei L . Epithelial-Mesenchymal Transition in tumor microenvironment. Cell Biosci. 2011; 1:29. PMC: 3179439. DOI: 10.1186/2045-3701-1-29. View